bibliographic entry 3080080 [be/3080080]
https://w3id.org/oc/corpus/be/3080080

is a
content
  • Scott, AM, Wiseman, G, Welt, S, Adjei, A, Lee, FT, Hopkins, W, Divgi, CR, Hanson, LH, Mitchell, P, Gansen, DN. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer, Clin Cancer Res, 2003, 9, 5, 1639, 47, PMID: 12738716
references